Schroder Investment Management Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-272,882
| Closed | -$4.66M | – | 1153 |
|
|
2025
Q1 | $4.66M | Buy |
272,882
+4,848
| +2% | +$82.8K | ﹤0.01% | 768 |
|
|
2024
Q4 | $4.47M | Sell |
268,034
-264,938
| -50% | -$4.42M | ﹤0.01% | 783 |
|
|
2024
Q3 | $8.36M | Buy |
532,972
+400,110
| +301% | +$6.28M | 0.01% | 696 |
|
|
2024
Q2 | $2.16M | Hold |
132,862
| – | – | ﹤0.01% | 919 |
|
|
2024
Q1 | $2.46M | Buy |
132,862
+71,160
| +115% | +$1.32M | ﹤0.01% | 894 |
|
|
2023
Q4 | $1.93M | Buy |
+61,702
| New | +$1.93M | ﹤0.01% | 915 |
|